Tag: BRWC

Blue Horseshoe Stocks: Options Recap & More

Updates on Yesterday’s Options Ideas

Both of our options ideas from yesterday’s premarket report returned some excellent chances for quick intraday profits. While it’s true that we signal Puts very rarely,  that didn’t stop us from sniffing out winning contracts!  

Macy’s, Inc. M –  After releasing disappointing sales figures for Q3 and gapping down considerably in premarket trading, Macy’s continued to plunge, registering a new 52-week low and creating all sort of opportunities within our targeted range, the M Weekly $47-43 Puts.

We had the $43’s run from 1.10-3.33; a move of 203%, and the $44’s turned in an even more impressive performance, shooting up 424% from .85-4.45. At the other end of the spectrum, the $47 Puts popped from 4.46 to 7.00 (+57%), but keep in mind that there were several sets of contracts in between, and traders were faced with potential gains regardless of the increment chosen!

____

Horizon Pharma plc HZNP – HZNP was the other play we were bearish on yesterday, looking at the HZNP Weekly $20-17 Puts. Just like the previously mentioned play, we were afforded the chance at gains no matter what strike price we chose within our selected range of contracts, as the stock continued to pull back.

$20 Puts – Daily Range: 1.70-3.00 – Max Gain: 76%
$19 Puts – Daily Range: 1.15-2.20 – Max Gain: 91%
$18 Puts – Daily Range: .90-1.66  – Max Gain: 46%
$17 Puts – Daily Range: .65-1.30  – Max Gain: 100%

___

FRESH OPTIONS IDEA:
JC Penney Company Inc. JCP

JC Penney got beaten back yesterday and looked oversold in our opinion, but the stock seems to be rebounding nicely in early trading today. We’re going to call attention to both a weekly and a longer term set of contracts that we want to monitor going forward. For intraday/week swing trades, we’ll look to JCP Weekly $8.50 Calls, and for an extended-term watch, we’ll go with the JCP 12/11 $9 and 9.50 Calls. We would be remiss if we failed to mention that JCP earnings are slated for release before market open tomorrow so things could get quite interesting, very soon.


Dolat Ventures, Inc. DOLV

We also want to quickly submit the following subpenny play for speculation. DOLV is going to be a bottom-watch play for us as we near week’s end. Indicators suggest a recovery could be in the cards, so we’ll be watching for the recording of higher highs and higher lows off of its recently established bottom.


Extended Watchlist:
BRWC, ZYXI, GACR, MCET

Blue Horseshoe Stocks: PZOO News & More

Pazoo, Inc. PZOO

We come back to touch base with PZOO this morning as the company has released an update on its marijuana testing facility in Las Vegas. It’s significant in that PZOO has secured a loan for the capital to put the finishing touches on the laboratory, the terms of which state that the full amount will be paid from the proceeds of the lab itself.

The company also made some lofty claims, namely that it has such an impressive roster of clients-in-waiting, that when the labs do open, they will be in a position to break even in the first month of operation! We’re being told that this cash infusion will have things on track for a November grand opening, so we’re going to begin to monitor PZOO more heavily in the weeks ahead as more updates are sure to be forthcoming.

We also want to point out the current setup on the PZOO chart on the annotated snapshot below:

WHIPPANY, N.J., Sept. 24, 2015 /PRNewswire/ — Pazoo, Inc. (OTC: PZOO) is pleased to report that Pazoo has received a $200,000 Loan to be paid back from the revenue and earnings of the Las Vegas Facility.  There can be no debt to equity conversion as this is a more conventional form of financing.

The Note holder was so impressed by the Las Vegas Lab, and more so by the amount of growers that have committed to exclusively test with Pazoo, Inc subsidiary MA & Associates, LLC, that he was comfortable to be paid back from the revenue and earnings that will be generated from the Lab.  In fact, based on the commitments from growers, Pazoo management is confident that the lab will be at least break even within the first 30 days of operation, and will quickly transition to profitability.

Pazoo expects to have the Colorado testing facility to officially be under the control of Harris Lee Colorado, LLC on or about October 14 and have the Las Vegas Facility operational and testing product in the latter part of the 4th quarter.

David Cunic, CEO, states, “The moment is finally upon us. This is going to be an watershed 4th quarter for Pazoo and hoping for an explosive 1st quarter of 2016. We are very excited for the ownership transition in Colorado.  We have several growers in Colorado that are just waiting for Harris Lee Colorado, LLC to take over so they can begin testing with Harris Lee Colorado, LLC. Everyone can just feel the momentum and it has energized the team to see what’s in front of us.”  >> Full PR

We also suggest that our readers check out the official webcast the company recently published which essentially addressed every facet of the business: >>>VIEW WEBCAST

Extended Watchlist:
ARWR, CNAT, EGYH, SGNL, BRWC